Insilico and CTFH team up to expedite first-in-class therapeutics using AI platform

[News]

Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program research collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd..

More... (https://www.news-medical.net/news/20191009/Insilico-and-CTFH-team-up-to-expedite-first-in-class-therapeutics-using-AI-platform.aspx)